Related Experiment Videos

[Treatment of onychomycoses]

Klára Halmy1

  • 1Kenézy Gyula Kórház-Rendelóintézet, Mikológiai Laboratórium, Debrecen.

Orvosi Hetilap
|November 25, 2003
PubMed

Insights

Onychomycosis, a fungal nail infection, is common and influenced by age and disease. Effective oral antifungal treatments like fluconazole, itraconazole, and terbinafine offer high success rates, especially for fingernails.

Area of Science:

  • Medical Mycology
  • Dermatology
  • Pharmacology

Context:

  • Onychomycosis is a prevalent fungal nail infection.
  • Factors influencing onychomycosis include age and predisposing diseases.
  • Toenails are more frequently affected than fingernails.

Purpose:

  • To review the prevalence, influencing factors, diagnosis, and treatment of onychomycosis.
  • To discuss the efficacy of oral antifungal agents and combination therapies.
  • To highlight considerations for treatment, including drug interactions and relapse prevention.

Summary:

  • Distal subungual onychomycosis, often caused by dermatophytes, is the most common type.
  • Newer diagnostic methods complement traditional mycological investigations.
  • Oral antifungals (fluconazole, itraconazole, terbinafine) are primary treatments, achieving 70-80% efficacy, particularly for fingernails.
  • Combination therapies (oral antifungals with topical treatments or procedures) can enhance outcomes.
  • Preventing relapse involves addressing fungal residues and disinfecting footwear.

Impact:

  • Improved understanding of onychomycosis contributes to better patient management.
  • Evidence-based treatment strategies can lead to higher cure rates and reduced recurrence.
  • Awareness of potential drug interactions and side effects ensures safer therapeutic choices.

Related Concept Videos